--- title: "Affinity Wealth Management LLC Acquires Shares of 126,301 Manulife Financial Co. (NYSE:MFC)" description: "Affinity Wealth Management LLC has acquired 126,301 shares of Manulife Financial Co. (NYSE:MFC) valued at approximately $3.93 million. This acquisition occurred in the first quarter, as disclosed to t" type: "news" locale: "en" url: "https://longbridge.com/en/news/243462336.md" published_at: "2025-06-06T11:06:38.000Z" --- # Affinity Wealth Management LLC Acquires Shares of 126,301 Manulife Financial Co. (NYSE:MFC) > Affinity Wealth Management LLC has acquired 126,301 shares of Manulife Financial Co. (NYSE:MFC) valued at approximately $3.93 million. This acquisition occurred in the first quarter, as disclosed to the SEC. Other hedge funds have also recently invested in Manulife, which has a market cap of $54.88 billion and a current stock price of $32.04. The company recently announced a quarterly dividend of $0.3194, reflecting a yield of 3.99%. Analysts have a consensus 'Buy' rating for the stock, with a price target of $45.67. Affinity Wealth Management LLC acquired a new stake in shares of Manulife Financial Co. (NYSE:MFC - Free Report) TSE: MFC in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 126,301 shares of the financial services provider's stock, valued at approximately $3,934,000. Get **Manulife Financial** alerts: - 5 Undervalued Stocks To Secure Your High Yield Portfolio A number of other hedge funds also recently bought and sold shares of the company. Lee Danner & Bass Inc. purchased a new stake in shares of Manulife Financial in the fourth quarter worth approximately $31,000. Stonebridge Financial Group LLC acquired a new stake in shares of Manulife Financial in the fourth quarter worth $34,000. Golden State Wealth Management LLC acquired a new stake in shares of Manulife Financial in the fourth quarter worth $35,000. Lazard Asset Management LLC acquired a new stake in Manulife Financial during the fourth quarter worth $35,000. Finally, Transce3nd LLC acquired a new stake in Manulife Financial during the fourth quarter worth $42,000. 52.56% of the stock is owned by hedge funds and other institutional investors. ## Manulife Financial Stock Up 0.3% Shares of MFC stock opened at $32.04 on Friday. The stock has a 50-day moving average price of $30.42 and a 200 day moving average price of $30.55. The firm has a market cap of $54.88 billion, a price-to-earnings ratio of 15.48, a PEG ratio of 1.11 and a beta of 1.00. Manulife Financial Co. has a 12 month low of $23.30 and a 12 month high of $33.07. - 3 High Short Interest Stocks that Investors are Getting Wrong Manulife Financial (NYSE:MFC - Get Free Report) TSE: MFC last announced its quarterly earnings data on Wednesday, May 7th. The financial services provider reported $0.69 EPS for the quarter, missing analysts' consensus estimates of $0.70 by ($0.01). The firm had revenue of $1.49 billion during the quarter. Manulife Financial had a return on equity of 15.98% and a net margin of 10.08%. During the same period last year, the firm posted $0.94 EPS. Sell-side analysts predict that Manulife Financial Co. will post 2.87 earnings per share for the current fiscal year. ## Manulife Financial Increases Dividend The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 19th. Investors of record on Wednesday, May 21st will be given a $0.3194 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 3.99%. This is a positive change from Manulife Financial's previous quarterly dividend of $0.31. The ex-dividend date of this dividend is Wednesday, May 21st. Manulife Financial's dividend payout ratio (DPR) is presently 63.87%. ## Analyst Ratings Changes A number of equities research analysts have weighed in on the stock. Royal Bank of Canada lifted their price target on shares of Manulife Financial from $49.00 to $51.00 and gave the stock an "outperform" rating in a research note on Friday, February 21st. Morgan Stanley set a $46.00 price objective on Manulife Financial in a report on Monday, May 19th. One investment analyst has rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, Manulife Financial has an average rating of "Buy" and a consensus price target of $45.67. **Read Our Latest Research Report on Manulife Financial** ## About Manulife Financial (Free Report) Manulife Financial Corporation, together with its subsidiaries, provides financial products and services in the United States, Canada, Asia, and internationally. The company operates through Wealth and Asset Management Businesses; Insurance and Annuity Products; and Corporate and Other segments. The Wealth and Asset Management Businesses segment offers investment advice and solutions to retirement, retail, and institutional clients through multiple distribution channels, including agents and brokers affiliated with the company, independent securities brokerage firms and financial advisors pension plan consultants, and banks. ## Featured Articles - Five stocks we like better than Manulife Financial - 5 discounted opportunities for dividend growth investors - Is Meta Plotting a Stablecoin Comeback Years After Libra's Flop? - Stock Market Holidays 2022-2025 - Here’s When the NYSE and NASDAQ Will be Closed - Silver's Options Sizzle: Are Traders Betting on a Breakout? - Comparing and Trading High PE Ratio Stocks - AT&T: Is This Telecom Giant a Buy or a Bye for Your Portfolio? **Want to see what other hedge funds are holding MFC?** Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Manulife Financial Co. (NYSE:MFC - Free Report) TSE: MFC. *This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.* ## Should You Invest $1,000 in Manulife Financial Right Now? Before you consider Manulife Financial, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Manulife Financial wasn't on the list. While Manulife Financial currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [MFC.US - Manulife Financial](https://longbridge.com/en/quote/MFC.US.md) - [00945.HK - MANULIFE-S](https://longbridge.com/en/quote/00945.HK.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | 【每日通告】嵐圖汽車 (7489) 介紹形式上市，速騰聚創 (2498) 受惠產品銷量增長，去年虧損大幅收窄 | 嵐圖汽車預計於 3 月 19 日以介紹形式上市，H 股數目約 8.85 億股。新明中國建議進行 1 供 6 供股，集資超過 1 億元，主要用於償還債務。速騰聚創預計去年虧損大幅收窄，主要受益於雷射雷達產品銷量增長。宏利金融獲準回購併註銷最多 | [Link](https://longbridge.com/en/news/276404702.md) | | 宏利金融簡報：宣佈正常的股票回購計劃，約佔已發行和流通普通股的 2.5% | 宏利金融簡報：宣佈正常的發行人回購計劃，約佔已發行和流通普通股的 2.5% | [Link](https://longbridge.com/en/news/276381436.md) | | 傳 OpenAI 最新融資有望突破 7800 億，亞馬遜、英偉達等參與投資 | OpenAI 即將完成新一輪融資的第一階段，預計融資額將超過 1,000 億美元，創下紀錄。首輪融資主要來自亞馬遜、軟銀、英偉達和微軟等戰略投資者，預計在本月底前確定投資方案。隨著 OpenAI 計劃進行基礎設施投資，公司整體估值可能超過 | [Link](https://longbridge.com/en/news/276419176.md) | | 智雲健康 (9955) 發盈警，2025 年度預期虧損擴大至 8.8-9.8 億人民幣 | 智雲健康發出盈利警告，預計 2025 年度淨虧損將擴大至 8.8 億至 9.8 億元人民幣，較 2024 年度的 4.91 億元顯著增加。董事會指出，虧損增加主要因集團推進戰略轉型及業務重組，出售子公司確認大額減值虧損，並就涉及重大訴訟的項 | [Link](https://longbridge.com/en/news/276431220.md) | | 傳 AMD 將向雲端運算初創 Crusoe 提供逾 23 億貸款擔保 | 超微半導體 (AMD) 將為雲端運算初創公司 Crusoe 提供 3 億美元的貸款擔保，用於採購及部署 AI 晶片。若 Crusoe 無法獲得客户，AMD 將租回其晶片。Crusoe 正轉型為 AI 基礎設施提供商，專注於 AI 雲端及數據 | [Link](https://longbridge.com/en/news/276420524.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.